Engflag

Acyclovir 5%

Quick links to important sections

Acyclovir 5%

Acyclovir 5__FR

Method of action: Antibiotics And Chemotherapeutics For Dermatological Use, Antiherpetic, Antivirals For Systemic Use

Treatment option: Varicella-Zoster, Chickenpox, Genital Herpes, Cold Sore, Skin Conditions, Infection, Empeines, Shingles, Smallpox

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Acyclovir 5%

What is Acyclovir 5%?

Acyclovir 5% is a topical antiviral medication specifically formulated to treat certain viral skin infections. It belongs to a class of drugs known as synthetic purine nucleoside analogues. Unlike oral or intravenous forms of the medication, the 5% concentration in a cream or ointment base is designed for localized application directly to the affected area of the skin.

Mechanism of Action

The primary function of acyclovir is to interfere with the replication process of specific viruses. Once applied to the skin and absorbed into the infected cells, the medication undergoes a chemical conversion that allows it to inhibit the activity of viral DNA polymerase. By acting as a deceptive building block for viral DNA, it prevents the virus from successfully copying its genetic material. This process stops the virus from multiplying and spreading to healthy neighboring cells.

Primary Uses

Acyclovir 5% is most commonly utilized for the management of recurrent herpes labialis, frequently referred to as cold sores or fever blisters. It is specifically active against the herpes simplex virus (HSV). While the medication helps to manage the symptoms and can shorten the duration of an outbreak by slowing viral shedding, it is important to note that it is not a cure for the underlying viral infection. The virus typically remains dormant in the nerve bodies of the body even after the physical symptoms on the skin have cleared.

Regulatory References

  1. official labeling (DailyMed, Label: ACYCLOVIR cream)

What side effects are possible with Acyclovir 5%?

Possible side effects and safety information

The safety profile of Acyclovir 5% topical preparation is primarily defined by localized reactions at the application site, reflecting its primary action on the skin and minimal systemic absorption. The official documentation categorizes possible effects into distinct frequency tiers based on clinical use data.

Officially Documented Adverse Reactions

Classification Examples of Reactions
Common (up to 1 in 10) Burning or stinging immediately upon application, pruritus (itching).
Uncommon (up to 1 in 100) Mild drying or flaking of the skin, erythema (redness).
Rare (up to 1 in 1,000) Contact dermatitis (a local hypersensitivity reaction).
Very Rare (less than 1 in 10,000) Immediate hypersensitivity reactions, including angioedema (swelling) and urticaria (hives).

Serious Adverse Reactions and Safety Constraints

The most clinically significant adverse reactions are related to the Immune System Disorders and are classified as Very Rare. These serious reactions, such as angioedema and urticaria, are associated with a known contraindication against the medicine in individuals with a history of hypersensitivity to aciclovir, valaciclovir, or any components in the formulation.

Regulatory safety information notes that local effects like burning and stinging are often transient and occur immediately upon initial application. Due to the formulation's low systemic absorption, official documents do not specify differing safety profiles for special populations like older adults or those with renal impairment.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose Likelihood and Manifestations

Overdosage with Acyclovir 5% topical preparation is considered unlikely due to its minimal absorption into the bloodstream following external application. Regulatory information confirms that systemic exposure from the intended use is limited. Consequently, specific clinical signs or symptoms of systemic overdose are generally not documented following topical use in government-authorized prescribing information.

Accidental Ingestion and Emergency Action

The primary scenario addressed in official regulatory documents is the accidental oral ingestion of the cream. Even though no unwanted effects are expected from accidentally swallowing the entire contents of a standard small tube, it is a regulatory requirement that immediate medical attention be sought if this occurs.

If the product is swallowed, users must call a poison control center immediately or contact emergency medical services. This action is mandated regardless of whether symptoms are present.

Supportive Measures and Antidote

Regarding procedural steps, official safety data advises rinsing the mouth with water if the person is conscious. Users are also explicitly cautioned not to induce vomiting unless specifically advised to do so by a physician or poison control center. Regulatory labeling confirms that no specific antidote is recommended for managing an overdose of this topical preparation.

Therapeutic Uses of Acyclovir 5%

What Acyclovir 5% Treats: Main Uses and Benefits

Acyclovir 5% cream is an antiviral medicine that is commonly used across conditions presenting with acute episodes caused by the Herpes Simplex Virus (HSV). It is considered relevant in contexts involving episodic or fluctuating manifestations, such as recurrent herpes labialis (cold sores). This topical preparation plays a role in managing symptoms linked to organ-specific functional stress.

This medicine may assist with easing symptom clusters that interfere with daily comfort during an acute episode. It is relevant for easing symptoms related to inflammatory or irritative states, such as the tingling, itching, or redness that often precede a visible cold sore. The support provided is commonly used to help with acute or episodic changes. The overall support provided helps improve day-to-day comfort during symptomatic periods, and supports patients during difficult episodes by easing distress. This approach contributes to easing the overall symptom load.

Quick Fact: Helps ease symptoms related to physical discomfort

Regulatory References

  1. FDA-Approved Labeling for Acyclovir Cream

Eligibility and Restrictions for Use

Who can and cannot use Acyclovir 5%? — Official Eligibility Information

Official regulatory information defines specific populations that are eligible to use Acyclovir 5% cream and groups that must not use it. Eligibility is determined by age, immune status, and hypersensitivity.

Eligibility Status

The primary population for whom use is established includes immunocompetent adults and adolescents 12 years of age and older.

Age Restriction: Use is not established and therefore not recommended for children under the age of 12.

Immune Status Restriction: Use is also not established for immunocompromised patients (such as those with HIV or receiving transplants), who may require systemic, rather than topical, treatment.

Groups Who Must Not Use (Contraindicated)

Hypersensitivity: Acyclovir 5% cream is contraindicated for any individual with a known hypersensitivity or allergy to the active substance, acyclovir (or its prodrug, valacyclovir), or to any of the other ingredients in the formulation. This is an absolute exclusion.

Application Site Restriction: The cream is for cutaneous use only on the external aspects of the lips and face. Application to the eye, inside the mouth or nose, or other mucous membranes is prohibited as the drug is not intended for these sites.

Pregnancy and Lactation: Use during pregnancy should occur only if the potential benefit outweighs the potential risk. Nursing mothers with active lesions near the breast should avoid nursing.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Acyclovir 5% topical preparations (cream and ointment) is defined primarily by the absence of systemic interaction risks.

Interaction Scope and Risk Classification

Official government drug labeling across international health authorities confirms that clinically significant drug–drug interactions are highly unlikely when using the 5% topical formulation.

This conclusion is based on pharmacokinetic data showing minimal systemic absorption after application to the skin. Plasma concentrations of the active ingredient are too low to cause the metabolic (e.g., CYP enzyme-mediated) or transporter-mediated interactions that are associated with the oral or intravenous forms of Acyclovir.

As a result, regulatory documents state that there are no documented contraindicated combinations or officially classified clinically significant interactions with other medicinal products.

Documented Topical and Substance Restrictions

While systemic interactions are not documented, a procedural restriction exists regarding the local use of the product:

  • Other Topical Products: Official labeling restricts the co-application of other skin preparations or medicines on the exact treatment area. This restriction is a localized administration rule to prevent potential dilution of the cream or changes in local efficacy, not a systemic interaction.
  • Food, Alcohol, or Supplements: No specific interactions or restrictions are documented in official regulatory sources concerning the use of the 5% topical preparation with food, alcohol, or herbal products.

Mechanism of Action

How Acyclovir 5% Works: Mechanism of Action

The mechanism of Acyclovir is defined by highly selective targeting and disruption of the viral reproductive cycle, such that its biological activity is preferentially concentrated within infected cells.

Selective Activation by Viral Enzymes

The drug functions as a prodrug, requiring activation only within the target cells. This process is initiated by the viral enzyme, thymidine kinase (vTK), which is unique to the targeted virus (e.g., Herpes Simplex Virus) and is absent in healthy cells. The vTK phosphorylates Acyclovir, initiating a cascade that creates the active metabolite, Aciclovir triphosphate (ACV-TP). This mechanism ensures the active compound is predominantly formed where it is needed, limiting the formation of the active compound primarily to vTK-expressing cells.

Arrest of Viral DNA Synthesis

The active metabolite, ACV-TP, targets the virus's ability to replicate its genetic material. ACV-TP acts as a competitive inhibitor against the viral DNA polymerase enzyme and is incorporated into the growing viral DNA strand. Since it lacks the required attachment site, its incorporation results in irreversible DNA chain termination. This blockade of the viral genetic material supports the physiological suppression of viral multiplication and limits the propagation of new infectious particles locally.

Dosage and Administration Information

How to Use Acyclovir 5% Topical Cream

The administration of Acyclovir 5% topical cream is structured by guidelines that dictate the route, timing, frequency, and duration of the short-term treatment course. This medicine is strictly for topical use (cutaneous) on the external skin, and its application must be initiated at the earliest sign or symptom of a recurrent episode, such as the tingling, itching, or redness that precedes a visible lesion.

Official Administration Guidelines

Feature Instruction
Route Restriction Topical use only on the skin surface.
Dosing Schedule Apply a quantity sufficient to cover the entire affected area and its outer margin.
Frequency Application is required 5 times per day, generally spaced throughout the waking hours.
Duration The standard course is 4 days. Some standard protocols permit continuation for up to 10 days if healing is incomplete.
Age-Group Rule The application schedule and dosage are uniform for adults and adolescents 12 years and older.

Administration Protocol and Restrictions

The required application schedule is a high-frequency, short-term pattern of 5 times daily. Consistent use requires resuming the routine as soon as possible if an application is missed. It is an explicit restriction that the cream must not be applied to mucous membranes, including the inside of the mouth, nose, or eyes. Users must adhere to the procedural requirement of washing hands thoroughly before and after each use. This approach ensures the medicine is delivered precisely to the site of need.

Recent Clinical Evidence

Acyclovir 5%: Recent Clinical Evidence

Overview of Investigation and Study Focus

Research has been conducted to investigate the drug’s mechanism, which involves interference with viral replication within infected cells. Early studies examined how the drug’s properties were observed in relation to specific viral markers. The primary goal of clinical trials was to measure changes in the duration of outbreaks and the severity of symptoms in participants with cold sores (herpes labialis).

Summary of Clinical Findings

Clinical trials have primarily focused on the effectiveness of Acyclovir 5% cream when applied at the earliest sign of a cold sore episode. These studies measured participant outcomes using objective criteria, such as the total time required for lesions to heal.

Key findings reported in the research generally indicate that the application of Acyclovir 5% cream is associated with a shorter duration of the cold sore episode compared to placebo.

Safety and Observational Data

The safety profile has been characterized across various clinical settings. Most data collected reports that Acyclovir 5% is locally tolerated. The incidence of certain events reported by participants was low and typically localized to the application site.

Reported application site reactions often include:

  • Dryness
  • Mild stinging or burning
  • Temporary redness or irritation

Research has documented that these localized effects are usually temporary and do not typically lead to the discontinuation of treatment. Studies focusing on long-term use have analyzed data related to the recurrence rates and overall usage patterns in participants.

Frequently Asked Questions (FAQ)

Common questions about Acyclovir 5% (FAQ)

Q: How quickly do people typically notice a difference after using Acyclovir 5%?

Clinical trials and official evidence indicate that Acyclovir 5% cream is associated with a shortened duration of cold sore episodes compared to not using the active ingredient. Specifically, studies have found that the mean duration of an outbreak was reduced by approximately one-half day when the cream was used. Official guidelines define the appropriate timing for application, recommending it be initiated at the earliest sign of a recurrent episode.

Q: Is Acyclovir 5% absorbed into the bloodstream?

Official drug labeling confirms that Acyclovir 5% is minimally absorbed systemically following topical application to the skin. This means that plasma concentrations of the drug in the bloodstream are generally very low or barely detectable. This minimal absorption is the reason clinically significant systemic drug interactions are not expected.

Q: Can people who are pregnant or breastfeeding use Acyclovir 5%?

Regarding pregnancy, official documents state that due to minimal systemic absorption, the use of Acyclovir 5% cream is not expected to result in fetal exposure. For breastfeeding mothers, the minimal absorption suggests that use is not expected to result in exposure of the child to the drug. Official documents advise that a healthcare provider should be consulted before use during pregnancy or lactation.

Q: Is it true that Acyclovir 5% may only shorten the healing time slightly?

Studies summarized in official product information measured the total time needed for lesions to heal. The findings indicate that the 5% cream shortened the mean duration of an episode by approximately one-half day when compared to a placebo. This measure of change is reported objectively in clinical data.

Q: Can prolonged use of Acyclovir 5% lead to drug resistance?

The development of drug resistance has not been commonly observed in clinical practice related to the use of the topical 5% formulation. However, official sources indicate that the possibility of viral resistance exists, based on the drug’s mechanism of action.

Q: Can Acyclovir 5% be used for shingles or genital herpes?

According to the official Indications and Usage sections, Acyclovir 5% topical cream is only indicated for the treatment of recurrent herpes labialis (cold sores). It is not approved for the use of shingles or genital herpes.

Q: What information is available about the safety of Acyclovir 5% use in the elderly?

Official documents state that reported clinical experience has not identified differences in responses between elderly and younger patients. This lack of difference is expected due to the minimal systemic absorption of the topical cream, which means the drug is mainly acting only on the applied skin area.

Q: Does Acyclovir 5% treat other viral skin infections, like warts?

No. The cream is specifically indicated for the treatment of recurrent herpes labialis (cold sores) only. It is not approved by regulatory authorities for the use of other viral skin infections, such as warts.

Q: Does Acyclovir 5% have any known interactions with alcohol?

Regulatory documents on drug interactions for Acyclovir 5% topical cream confirm that no clinically significant interactions have been identified. Official labeling reports that no specific restrictions concerning the use of the cream with alcohol, food, or supplements are documented.

Q: Is Acyclovir 5% for the primary outbreak or for recurrent episodes?

The official Indications and Usage section states that Acyclovir 5% cream is indicated for the treatment of recurrent herpes labialis (cold sores). The treatment is designed to be initiated at the earliest sign of a recurring episode.

Q: What should I do if I accidentally get Acyclovir 5% in my eyes or mouth?

The cream must not be used on mucous membranes. Official patient information notes that if the cream gets into the eyes, rinsing the area with water is the suggested action. In the event of accidental swallowing, official documents suggest contacting a healthcare provider for advice.

Q: Is Acyclovir 5% cream safe to use around my nose?

Official labeling indicates the cream is for use on the external aspect of the lips and face. It is restricted from application to mucous membranes, such as the inside of the nose. Application is intended only for the external skin area.

Q: Is Acyclovir 5% commonly known by any other trade names?

Acyclovir is the generic name for the active ingredient. The drug is available under various trade names globally; the most commonly cited brand name for Acyclovir in official drug summaries is Zovirax.

How should Acyclovir 5% be stored and disposed of?

How to Store and Dispose of Acyclovir 5% (Topical)

Official regulatory guidelines define specific conditions for storing and disposing of Acyclovir 5% cream or ointment to maintain its stability and effectiveness.

Storage and Stability

  • Temperature Control: Store the medication at room temperature, typically between 15°C and 25°C (59°F and 77°F). It is mandatory to keep it from freezing and to not refrigerate the product.
  • Environmental Protection: Keep the container tightly closed in its original packaging. Store away from excess heat, moisture, and direct light.
  • Child Safety: Medication must be kept out of the sight and reach of children.
  • Shelf Life: Do not use the product after the expiration date printed on the label.

Disposal Instructions

  • Proper Disposal: Unused or expired Acyclovir 5% should not be disposed of in household trash or poured down a sink or toilet, as this may harm the environment.
  • Take-Back Programs: Utilize a drug take-back program or a community disposal location for proper disposal, as advised by regulatory authorities.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagEgypt

Equivalent of Acyclovir 5% found in:

A-Z Index: